https://www.selleckchem.com/products/1-thioglycerol.html ncia sin enfermedad mediante el uso de quimioterapia adyuvante (p less then 0,001).LIMITACIONESEstudio limitado por su diseño retrospectivo.CONCLUSIÓNLa tinción de elastina contribuyó a un aumento considerable en la detección de IV. IV puede ser un poderoso predictor de supervivencia sin enfermedad deficiente más allá de las metástasis de los ganglios linfáticos cuando se limita al área pericólica y es útil para decidir el uso de quimioterapia adyuvante en el cáncer de colon en estadío II. Consulte Video Resumen en http//links.lww.com/DCR/B573. (Traducción-Dr. Adrian Ortega). A recent Norwegian moratorium challenged the status quo of transanal total mesorectal excision for rectal cancer by reporting increased early multifocal local recurrences. The aim of this systematic review and meta-analysis was to evaluate the local recurrence rates following transanal total mesorectal excision as well as to assess statistical, clinical, and methodological bias in reports published to date. The PubMed and MEDLINE (via Ovid) databases were systematically searched. Descriptive or comparative studies reporting rates of local recurrence at a median follow-up of 6 months (or more) after transanal total mesorectal excision were included. Patients underwent transanal total mesorectal excision. Local recurrence was any recurrence located in the pelvic surgery site. The untransformed proportion method of 1-arm meta-analysis was utilized. Untransformed percent proportion with 95% confidence interval was reported. Ad hoc meta-regression with the Omnibus test was utilized to assess risk factofound a pooled rate of local recurrence of 3.4% at 20 months. However, given the substantial clinical and methodological heterogeneity across the studies, the evidence for or against transanal total mesorectal excision is inconclusive at this time. This systematic review found a pooled rate of local recurrence of 3.4% at 20 months. However, given